邻近类别 圖書 [0/1] 期刊論文 [106/107] 类别统计 近3年内发表的文件:2(8.70%) 含全文笔数:22(95.65%) 文件下载次数统计 下载大于0次:22(100.00%) 下载大于100次:20(90.91%) 全文下载总次数:10676(19.74%) 最后更新时间: 2024-12-12 09:19 上传排行 数据加载中..... 下载排行 数据加载中..... 最近上传 Biomarkers as potential indicators ... Cognitive frailty: A prospective ob... Investigation the main effects of g... Genomewide sex-by-snp interaction s... Identification of genetic variants ... Distinct genetic profiles of peptic... Identifying variants in nf1a gene t... Identification of genetic loci for ... Apoptosis pathway CASP10 gene assoc... Genome-wide association study of tr...

跳至: (选择年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (选择月份) January February March April May June July August September October November December 或输入年份:

由新到旧排序 由最旧的开始

显示项目1-23 / 23. (共1页) 1  每页显示[10|25|50]项目

日期	题名	關聯
2023-07	Cognitive frailty: A prospective observational cohort study from aged 60 to 66	British Journal of Pharmacology. 2023 Jul;180(Suppl. 1):254.
2023-07	Biomarkers as potential indicators for substance use disorder patient care	British Journal of Pharmacology. 2023 Jul;180(Suppl. 1):273-273.
2019-10	Investigation the main effects of genetic variants and polygenic risk score of personality on suicidal behavior	European Neuropsychopharmacology. 2019 Oct;29:S146-S147.
2019-08	Genomewide sex-by-snp interaction scan identifies adgrv1 for the sex differences of opioid dependence in african american and supporting evidence in relations with treatment side effects in the asian population	European Neuropsychopharmacology. 2019 Aug;29(Suppl. 4):S1183-S1184.
2019-01	Identifying variants in nf1a gene to be associated with seasonal pattern and susceptibility for depression through a candidate gene approach	European Neuropsychopharmacology. 2019 Jan;29(Suppl. 3):S857-S858.
2019-01	Distinct genetic profiles of peptic ulcer in individuals with depression	European Neuropsychopharmacology. 2019 Jan;29(Suppl. 3):S905-S906.
2019-01	Identification of genetic variants for suicidal behaviors in patients with bipolar or major depressive disorders	European Neuropsychopharmacology. 2019 Jan;29(Suppl. 3):S988-S989.
2017-10	Identification of genetic loci for treatment response of selective serotonin reuptake inhibitors on empirically defined depression syndromal factors	European Neuropsychopharmacology. 2017 Oct;27:S390.
2017-05	Genome-wide association study of treatment emergent suicidal ideation with antidepressant use	Bipolar Disorders. 2017 May;19(Suppl. 1):113-114.
2016-10	Apoptosis pathway CASP10 gene associated with methadone dose and interacted with GRK5	European Neuropsychopharmacology. 2016 Oct;26(Suppl. 2):S693-S694.
2015-01	Change of suicidality among heroin users: 1 month after methadone maintenance treatment	Drug and Alcohol Dependence. 2015 Jan;146:e17.
2013-04	Comparing multiple testing correction methods between two softwares for single nucleotide polymorphisms association analyses: Using OPRD1 and diastolic blood pressure in methadone maintenance patients as an example	2013 IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB). 2013 Apr:154-159.
2012-03	CYP1A2 genetic polymorphisms associated with antidepressant escitalopram metabolism and adverse reactions at early stage	Clinical Pharmacology and Therapeutics. 2012 Mar;91(Suppl. 1):S62.
2011-05	The genetic polymorphisms in ALDH2 influence the methadone dose and adverse reactions in patients with heroin addiction	Drug Metabolism Reviews. 2011 May;43(Suppl.1):26.
2011-05	Genetic polymorphisms of CYP2C19 associated with the side effect and serum concentrations of antidepressant paroxetine	Drug Metabolism Reviews. 2011 May;43(Suppl.1):25-26.
2011-05	Genetic polymorphisms in PXR associated with serum concentration and metabolism to treatment with the antidepressant paroxetine	Drug Metabolism Reviews. 2011 May;43(Suppl.1):71.
2011-05	CACNG2 is associated with delusion-hallucination symptom dimension of schizophrenia, but not with clozapine treatment outcome	Biological Psychiatry. 2011 May;69(9 Suppl. 1):281S.
2011-05	Opioid receptor Mu1 genetic polymorphisms influence QT prolongation and insomnia in methadone maintenance patients	Biological Psychiatry. 2011 May;69(9 Suppl.1):229S-230S.
2010-05	Good responders have higher plasma concentrations of aripiprazole in patients with schizophrenia	International Journal of Neuropsychopharmacology. 2010 May;13(Suppl. S1):204.
2009-10	Cytochrome P-450 Isozyme 2C19 Genetic Polymorphisms are Associated with Plasma Concentrations of Escitalopram	Therapeutic Drug Monitoring. 2009 Oct;31(5):166.
2008-12-12	A protein interaction based model for schizophrenia study	BMC Bioinformatics. 2008 Dec 12;9(Suppl. 12):Article number S23.
2006-10	Systematic mutation screening study for DISC1 and NRG1 in schizophrenia	American Journal of Medical Genetics Part B-Neuropsychiatric Genetics. 2006 Oct;141B(7):794.
2006-10	Systematic SNP polymorphism screening for schizophrenia candidate gene of calcium channel, voltage-dependent, gamma subunit (CACNG2)	American Journal of Medical Genetics Part B-Neuropsychiatric Genetics. 2006 Oct;141B(7):802.

显示项目1-23 / 23. (共1页) 1  每页显示[10|25|50]项目